Merck & Co Inc (MRK)

111.07 -1.23 (-1.10%) USD  |  NYSE  |  May 26, 16:00
111.07 0.00 (0.00%) Pre-Market: 20:00
More

Merck News

News

Headline
Wire
Time (ET)
Warren Buffett Stocks: What's Inside Berkshire Hathaway's Portfolio?
Yahoo
05/26 12:34
Merck Says Keytruda Plus Lenvima Shows Long-Term Survival Benefit Versus Sunitinib for Advanced Renal Cell Carcinoma
MT Newswires
05/25 17:51
KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Demonstrates Long-Term, Durable Survival Benefit Versus Sunitinib as First-Line Treatment for Patients With Advanced Renal Cell Carcinoma
Yahoo
05/25 17:00
Is Pfizer Stock A Buy As It Leaps Into The Red-Hot Weight-Loss Race?
Yahoo
05/25 11:43
Investors Heavily Search Merck & Co., Inc. (MRK): Here is What You Need to Know
Yahoo
05/25 09:00
14 Best Biotech Stocks To Buy According To Hedge Funds
Yahoo
05/25 04:03
14 Best Healthcare Dividend Stocks to Buy
Yahoo
05/24 09:33
7 Stocks That Could Be the Next $2 Trillion-Dollar Companies
Yahoo
05/23 20:18
--Merck Maintains Quarterly Dividend at $0.73 per Share, Payable July 10 to Shareholders of Record June 15
MT Newswires
05/23 15:55
Merck declares $0.73 dividend
SA Breaking News
05/23 14:52
Merck Announces Third-Quarter 2023 Dividend
Yahoo
05/23 14:45
Fed Rate Increases Hit Small Businesses the Hardest
Yahoo
05/22 05:30
Intensity Therapeutics upsizes proposed IPO to $15M from $8M
SA Breaking News
05/19 18:59
Catalyst watch: Eyes on Ford event, Virgin Galactic launch, Nvidia earnings and Microsoft conference
SA Breaking News
05/19 15:00
3 Undervalued Pharma Stocks to Buy for High Total Returns
Yahoo
05/19 11:27
Supreme Court rules against Amgen in Repatha patent dispute with Sanofi/ Regeneron
SA Breaking News
05/18 12:13
25 Most Prescribed Medication in the World
Yahoo
05/18 07:25
Shhh! 3 Healthcare Stocks Quietly Hitting 52-Week Highs
Yahoo
05/17 16:47
Fed, labor market concerns showing 'some dents in the armor of the consumer': Strategist
Yahoo
05/17 16:26
Sector Update: Health Care Stocks Steady in Afternoon Trading
MT Newswires
05/17 14:07
Drugmakers Eye $23 Billion Biotech Argenx Ahead of Key Data
Yahoo
05/17 10:21
Immutep Says Combination of Efti With Merck's Keytruda Achieved More Favorable Survival Period in Lung Cancer Patients
MT Newswires
05/17 10:18
Billionaire Ken Fisher’s Top 15 Dividend Stock Picks
Yahoo
05/16 10:53
Merck to Present Extensive New Research Demonstrating Significant Progress in the Treatment of Certain Earlier Stage Cancers and in Advancing Broad Oncology Pipeline at 2023 ASCO Annual Meeting
Yahoo
05/15 06:45
10 “Great” Earnings Reports Jim Cramer is Talking About
Yahoo
05/13 11:12
The Zacks Analyst Blog Highlights UnitedHealth Group, Merck, Texas Instruments, The TJX Companies and Johnson Controls International
Yahoo
05/12 06:35
Top Research Reports for UnitedHealth Group, Merck & Texas Instruments
Yahoo
05/11 16:14
US stocks and FTSE 100 lower as BoE hikes rates again
Yahoo
05/11 03:49
15 Biggest Immunotherapy Companies in the World
Yahoo
05/09 16:09
ALX Oncology Says First Patient Dosed in Phase 2 Trial of Ovarian Cancer Combination Therapy
MT Newswires
05/09 11:19
Merck Announces Global Grants Program To Improve Access to Quality Health Care in Underserved Communities
Accesswire
05/08 14:45
Merck & Co. Files Six-Part Shelf Offering of Unsecured Senior Debt Obligation Notes
MT Newswires
05/08 09:36
AstraZeneca, Merck's Koselugo Approved in China for Neurofibromas in Children
MT Newswires
05/08 06:48
Insider Sell: Merck & Co.
MT Newswires
05/05 16:56
WHO meeting is set to decide whether to end COVID emergency
SA Breaking News
05/04 14:28
Moderna (MRNA) Q1 Earnings & Sales Top Estimates, Stock Up 2%
Yahoo
05/04 14:01
Here is What to Know Beyond Why Merck & Co., Inc. (MRK) is a Trending Stock
Yahoo
05/04 09:00
Moderna beats COVID vaccine sales expectations as deferred revenue rolls in
Yahoo
05/04 06:30
Insurers Can't Use War Argument: Court Rules in Favor of Merck in $1.4 Billion Cyberattack Coverage Case
Yahoo
05/03 15:52
Merck: Supporting Colleagues Working With Cancer
Yahoo
05/03 15:00
NGM Biopharmaceuticals a buy at Citi on oncology assets
SA Breaking News
05/03 11:44
Merck to Participate in Bank of America Securities 2023 Healthcare Conference
Yahoo
05/03 06:45
Merck’s Insurers On the Hook in $1.4 Billion NotPetya Attack, Court Says
Yahoo
05/02 15:42
Insider Sell: Merck & Co.
MT Newswires
05/02 12:00
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Spectrum Pharmaceuticals, Inc. (Nasdaq – SPPI), BELLUS Health Inc (Nasdaq – BLU), Prometheus Biosciences, Inc. (Nasdaq – RXDX), Univar Solutions Inc. (NYSE - UNVR)
Globe Newswire
05/01 12:56
--Atlantic Equities Adjusts Price Target on Merck to $129 From $127, Maintains Overweight Rating
MT Newswires
05/01 11:32
Sector Update: Health Care Stocks Steady Premarket Monday
MT Newswires
05/01 09:18
--Barclays Adjusts Price Target on Merck & Company to $130 From $128, Keeps Overweight Rating
MT Newswires
05/01 09:06
Merck Says US FDA Panel Backs Restricted Approval of Prostate Cancer Therapy
MT Newswires
05/01 03:50
Merck, AstraZeneca Lynparza wins limited label expansion endorsement
SA Breaking News
04/28 18:14
CORRECTED-UPDATE 2-US FDA panel backs restricted use of AstraZeneca's prostate cancer drug (April 28)
Yahoo
04/28 17:59
CORRECTED-US FDA panel backs AstraZeneca's prostate cancer drug (April 28)
Yahoo
04/28 17:39
Update on FDA Advisory Committee Vote on LYNPARZA® (olaparib) Plus Abiraterone and Prednisone or Prednisolone in First-Line Metastatic Castration-Resistant Prostate Cancer
Yahoo
04/28 17:30
Merck (MRK) Q1 2023 Earnings Call Transcript
Yahoo
04/28 15:34
Pharma Stock Roundup: MRK & Others Post Q1 Results, LLY Drug Shines in Obesity Study
Yahoo
04/28 12:47
Company News for Apr 28, 2023
Yahoo
04/28 09:17
10 Best May Dividend Stocks To Buy
Yahoo
04/28 02:56
FDA Casts Doubt on Merck/AstraZeneca's Cancer Drug for Prostate Cancer Ahead of Adcomm Meeting
Yahoo
04/27 16:44
Merck (MRK) Beats on Q1 Earnings and Sales, Ups 2023 View
Yahoo
04/27 12:44
Research Alert: CFRA Lowers View On Shares Of Merck & Co., Inc. To Buy From Strong Buy
MT Newswires
04/27 12:40
Why Merck Stock Is Trading Higher Today
Yahoo
04/27 11:33
Drugmakers brace for serious headwinds ahead
Yahoo
04/27 10:00
Drugmakers scout for deals, ramp up research spending
Yahoo
04/27 09:33
Thinking about buying stock in Merck, Enphase Energy, Tilray, Canopy Growth, or Hasbro?
PR Newswire
04/27 09:31
2 of These 3 Stocks Are Lifting the Dow, but 1 Is Holding It Back
Yahoo
04/27 09:26
Sector Update: Health Care Stocks Narrowly Mixed Pre-Bell Thursday
MT Newswires
04/27 09:20
Merck has strong quarter even as COVID-19 treatment tumble
Yahoo
04/27 08:43
Merck (MRK) Surpasses Q1 Earnings and Revenue Estimates
Yahoo
04/27 07:45
Merck Q1 Earnings, Revenue Slip
MT Newswires
04/27 07:01
Merck & Co posts first-quarter sales beat, raises guidance
Yahoo
04/27 06:47
Merck beats first-quarter expectations on Keytruda, Gardasil strength
Yahoo
04/27 06:38
-- GUIDANCE: (MRK) MERCK & CO. Forecasts Fiscal Year 2023 Revenue Range $57.70B - $58.90B
MT Newswires
04/27 06:38
-- GUIDANCE: (MRK) MERCK & CO. Forecasts Fiscal Year 2023 EPS Range $6.88 - $7.00
MT Newswires
04/27 06:38
-- Earnings Flash (MRK) MERCK & CO. Reports Q1 Revenue $14.49B
MT Newswires
04/27 06:38
-- Earnings Flash (MRK) MERCK & CO. Reports Q1 EPS $1.40
MT Newswires
04/27 06:37
Merck earnings better-than-expected on Keytruda, Gardasil strength
Yahoo
04/27 06:30
Merck Announces First-Quarter 2023 Financial Results
Yahoo
04/27 06:30
Meta Platforms, Hasbro and Comcast rise premarket; First Republic fall
Yahoo
04/27 04:19
Will the Keytruda wave buoy Merck's Q1 results once again?
SA Breaking News
04/26 11:48
Merck Keeps Striking Out on Expanding Its Cancer-Drug Juggernaut
Yahoo
04/26 08:00
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Spectrum Pharmaceuticals, Inc. (Nasdaq – SPPI), BELLUS Health Inc (Nasdaq – BLU), Prometheus Biosciences, Inc. (Nasdaq – RXDX), Univar Solutions Inc. (NYSE – UNVR)
Globe Newswire
04/25 12:46
11 Best Mid-Cap Healthcare Stocks To Buy Now
Yahoo
04/25 11:43
UBS Adjusts Merck & Company Price Target to $117 From $108, Maintains Neutral Rating
MT Newswires
04/25 10:42
What is behind biotech M&A resurgence?
SA Breaking News
04/23 12:00
Catalyst watch: Earnings blitz, Mobileye lockup expiration and the new one-day VIX debut
SA Breaking News
04/21 15:00
Thinking about trading options or stock in Humana, Spotify, Mastercard, Altria Group, or Merck?
PR Newswire
04/21 14:29
Earnings Week Ahead: Amazon, Meta Platforms, Alphabet, Coca-Cola, Boeing, and more
SA Breaking News
04/21 13:30
12 Best Pharma Dividend Stocks To Buy in 2023
Yahoo
04/21 12:16
Merck (MRK) to Report Q1 Earnings: What's in the Cards?
Yahoo
04/21 10:10
Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know
Yahoo
04/21 09:00
Analysts Estimate Merck (MRK) to Report a Decline in Earnings: What to Look Out for
Yahoo
04/20 10:02
Merck (MRK) Dips More Than Broader Markets: What You Should Know
Yahoo
04/19 17:45
Is Merck Stock a Screaming Buy After This $11 Billion Acquisition?
Yahoo
04/19 10:45
Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Merck & Co.
MT Newswires
04/19 00:35
Vaxcyte initiated at outperform at TD Cowen on pneumococcal vaccine
SA Breaking News
04/18 14:26
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: BELLUS Health Inc (Nasdaq – BLU), Prometheus Biosciences, Inc. (Nasdaq – RXDX), Univar Solutions Inc. (NYSE - UNVR)
Globe Newswire
04/18 10:06
Credit Suisse Downgrades Prometheus Biosciences to Neutral From Outperform on Heels of Announced Sale to Merck & Co., Raises Price Target to $200 From $139
MT Newswires
04/18 08:49
How to Tell Biotech’s Likely Winners From Losers
Yahoo
04/18 08:00
RBC Downgrades Prometheus Biosciences to Sector Perform From Outperform, Lifts Price Target to $200 From $140 on Merck Deal; Speculative Risk Kept
MT Newswires
04/18 07:59
Prometheus Biosciences, Inc. (RXDX) Stock Jumps 69.7%: Will It Continue to Soar?
Yahoo
04/18 03:19
Why did Moderna stock drop today? mRNA cancer therapy data
SA Breaking News
04/17 19:08
Hot Stocks: RXDX jumps 70% on MRK deal; TECK climbs; STT, GNTY fall on earnings news
SA Breaking News
04/17 17:50
Prometheus Biosciences stock soars amid $10.8 billion acquisition deal by Merck
Yahoo
04/17 15:51
Sector Update: Health Care Stocks Mostly Declining Monday Afternoon
MT Newswires
04/17 14:22
Merck/Prometheus: Big Pharma must swallow bigger premiums
Yahoo
04/17 13:28
Update: Prometheus Biosciences Surges After Merck's Takeover Announcement
MT Newswires
04/17 13:22
Moderna stock plunges following mixed analyst reviews of cancer vaccine data
Yahoo
04/17 13:17
Top Stories at Midday: More Banks Post Q1 Beat; Samsung May Favor Bing; US Builders Confidence Rises; Prometheus' $10.8 Billion Buyout Deal
MT Newswires
04/17 12:11
Why Shares of Prometheus Biosciences Are Soaring Monday
Yahoo
04/17 12:09
Moderna, Merck's Cancer Vaccines Exhibit Positive Outcomes Under Midstage Trial
Yahoo
04/17 10:38
Merck to take $10.3 billion R&D charge for Prometheus deal this year
Yahoo
04/17 10:06
Midday movers: Charles Schwab, Enphase Energy, Alphabet and more
Yahoo
04/17 09:51
Merck agrees to acquire Prometheus Biosciences
Yahoo
04/17 09:33
Sector Update: Health Care Stocks Higher Premarket Monday
MT Newswires
04/17 09:15
Sector Update: Health Care
MT Newswires
04/17 08:56
Mixed Economic Data, Bank Earnings Weighed Amid Higher Exchange-Traded Funds, Equity Futures in Pre-Bell Activity
MT Newswires
04/17 08:23
Top Premarket Gainers
MT Newswires
04/17 07:46
Merck Buying Prometheus Biosciences for $10.8 Billion to Enhance Immunology Portfolio
MT Newswires
04/17 06:53
Stocks Nudge Higher, Earnings On Deck, Merck Buys Prometheus, Netflix Axes 'Love Is Blind', Charles Schwab Reports - Five Things To Know
Yahoo
04/17 06:11
Big Bank Earnings Won’t Reveal If the Turmoil Is Over. Here’s What Will.
Yahoo
04/17 06:11
Merck, Moderna Say mRNA-4157, Keytruda Combination Show Enhanced Recurrence-Free Survival in Melanoma Phase 2 Trial
MT Newswires
04/17 05:30
Merck Reports 'Significantly Improved Overall Survival' in Phase 3 Study of Biliary Tract Cancer
MT Newswires
04/17 04:35
Moderna, Xpeng and Uber rise premarket; State Street falls
Yahoo
04/17 04:01
Merck to Acquire Prometheus Biosciences for $200 per Share
MT Newswires
04/17 03:25
Dow futures little changed as investors await corporate earnings
Yahoo
04/17 02:57
PRESS DIGEST- Wall Street Journal - April 17
Yahoo
04/17 01:21
Moderna, Merck post detailed Phase 2 data for mRNA cancer shot in melanoma
SA Breaking News
04/16 21:58
Merck to Acquire Prometheus Biosciences
Yahoo
04/16 18:20
UPDATE 1-Moderna/Merck cancer vaccine plus Keytruda delays skin cancer return
Yahoo
04/16 14:14
Moderna, Merck Show Progress Toward Cancer Vaccines
Yahoo
04/16 13:36
Moderna/Merck cancer vaccine plus Keytruda delays skin cancer return
Yahoo
04/16 11:04
CORRECTED-Moderna/Merck cancer vaccine plus Keytruda delays skin cancer return
Yahoo
04/16 11:00
Merck’s KEYTRUDA® (pembrolizumab) Plus Chemotherapy Significantly Improved Overall Survival Compared to Chemotherapy Alone in Patients With Advanced or Unresectable Biliary Tract Cancer
Yahoo
04/16 11:00
Moderna and Merck Announce mRNA-4157 (V940), an Investigational Individualized Neoantigen Therapy, in Combination with KEYTRUDA(R) (Pembrolizumab), Demonstrated Superior Recurrence-Free Survival in Patients with High-Risk Stage III/IV Melanoma Following Complete Resection versus KEYTRUDA
Accesswire
04/16 11:00
Merck inks ~$11B all-cash deal to acquire Prometheus
SA Breaking News
04/16 08:30
Merck Strengthens Immunology Pipeline with Acquisition of Prometheus Biosciences, Inc.
Business Wire
04/16 06:00
Merck said to be close to acquiring Prometheus Biosciences - WSJ
SA Breaking News
04/16 05:25
Merck to acquire Prometheus Biosciences for $10.8B
Yahoo
04/16 04:58
UPDATE 3-Merck to build out immunology presence with $11 billion Prometheus deal
Yahoo
04/16 01:23
Merck to build out immunology presence with $11 billion Prometheus deal
Yahoo
04/16 00:24
Bird Flu Keeps Raging. Some Say Vaccines Are Needed to Stop It.
Yahoo
04/14 10:00
Drug CEO: How the industry is fighting to sway impact of Texas abortion pill ruling
Yahoo
04/13 15:30
Pfizer collaborates with Sinopharm to expand in China
SA Breaking News
04/13 11:15
Merck Says US FDA Accepts New Supplemental Biologics License Application for Keytruda
MT Newswires
04/13 08:45
FDA Accepts Application for Merck’s KEYTRUDA® (pembrolizumab) Plus Chemotherapy as First-Line Treatment for Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
Yahoo
04/13 06:45
Citigroup Upgrades Merck & Company to Buy From Neutral, Adjusts Price Target to $130 From $105
MT Newswires
04/13 06:31
Delta Air Lines, Amazon, Stellantis rise premarket; Harley-Davidson falls
Yahoo
04/13 03:50
Merck Named One of Fortune’s 2023 100 Best Companies to Work For(R)
Accesswire
04/11 13:20
Guggenheim Adjusts Price Target on Merck to $124 From $123, Maintains Buy Rating
MT Newswires
04/11 10:49
U.S. launches $5B program to speed up development of next-gen COVID vaccines
SA Breaking News
04/10 22:25
Inflation Data Looms as US Equity Futures Fall in Premarket Session
MT Newswires
04/10 09:01
Merck & Co., Inc. (MRK) Is a Trending Stock: Facts to Know Before Betting on It
Yahoo
04/10 09:00
Rate Hike Concerns After Jobs Data Weigh on Exchange-Traded Funds, Equity Futures Pre-Bell
MT Newswires
04/10 08:07
Moderna Says Cancer Combination Therapy Received Priority Medicines Designation in Europe
MT Newswires
04/10 05:17
Catalyst Watch: Eyes on inflation data, big bank earnings
SA Breaking News
04/07 14:15
Merck, Eisai end two Keytruda combination trials after missing main goals
SA Breaking News
04/07 08:53
UPDATE 2-Merck, Eisai to discontinue late-stage study for skin cancer
Yahoo
04/07 07:21
Merck and Eisai Provide Update on Phase 3 Trials of KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) In Certain Patients With Advanced Melanoma (LEAP-003) and Metastatic Colorectal Cancer (LEAP-017)
Yahoo
04/07 06:45
MRNA-4157/V940, an Investigational Personalized MRNA Cancer Vaccine, in Combination With Keytruda(R) (Pembrolizumab), Receives Prime Scheme Designation From the European Medicines Agency for Adjuvant Treatment of Patients With High-Risk Stage III/IV Melanoma Following Complete Resection
Yahoo
04/06 17:00
Merck: Aiming for Health Equity and Business Success
Yahoo
04/06 14:15
WHO chief expects COVID emergency to end this year
SA Breaking News
04/06 14:14
Merck Working With Proxygen on Discovery, Development of Molecular Glue Degraders
MT Newswires
04/05 08:54
UPDATE 1-AstraZeneca says drug combo meets goal in late-stage ovarian cancer trial
Yahoo
04/05 02:39
Merck (MRK) Stock Moves -0.04%: What You Should Know
Yahoo
04/04 17:45
Merck Ranked No. 1 in the Pharmaceutical Industry Among Barron’s 100 Most Sustainable U.S. Companies 2023
Accesswire
04/04 13:10
Russia Warns As Finland Joins NATO, Spotify Highlights Struggle With Live Audio, Anticompetitive Charges Against Activision Blizzard: Today's Top Stories
Yahoo
04/04 11:52
FDA Approves Merck's Keytruda Combined With Seagen/Astellas's Padcev For Advanced Urothelial Cancer
Yahoo
04/04 11:08
After Denying Earlier, Pfizer & Merck Marginally Cut Prices For COVID-19 Treatments In China
Yahoo
04/04 11:06
Market Chatter: Pfizer, Merck Cut Prices of Respective COVID-19 Drugs in China
MT Newswires
04/04 10:41
US Court Favors Bayer In Lawsuit Against Merck On Talc Liabilities
Yahoo
04/04 09:47
Sector Update: Health Care Stocks Mixed Premarket
MT Newswires
04/04 09:27
12 Best Dow Stocks To Buy Right Now
Yahoo
04/04 06:21
UPDATE 2-Bayer defeats Merck in lawsuit over talc liabilities
Yahoo
04/03 18:44
Bayer defeats Merck in lawsuit over talc liabilities
Yahoo
04/03 17:51
Merck's KEYTRUDA, Padcev Combination Therapy For Treatment of Urothelial Cancer Approved by US FDA
MT Newswires
04/03 17:36
FDA Approves Merck’s KEYTRUDA® (pembrolizumab) in Combination With Padcev® (enfortumab vedotin-ejfv) for First-Line Treatment of Certain Patients With Locally Advanced or Metastatic Urothelial Cancer
Yahoo
04/03 17:00
10 Best April Dividend Stocks To Buy
Yahoo
04/03 07:52
PDS Biotechnology Plans Late-Stage Combo Trial in Head, Neck Cancer in Q4
MT Newswires
03/30 17:08
Starter Stock Portfolio: 15 Safe Stocks To Buy
Yahoo
03/30 11:02
Thinking about buying stock in Humana, Spotify, Mastercard, Altria Group, or Merck?
PR Newswire
03/30 09:31
Merck to Hold First-Quarter 2023 Sales and Earnings Conference Call on April 27
Yahoo
03/30 06:45
11 Best Dow Jones Dividend Stocks According to Hedge Funds
Yahoo
03/30 06:38
India exempts import tax on pricey rare disease medicines
Yahoo
03/30 05:18
Merck & Company Therapy Gets FDA Approval to Treat Solid Tumors
MT Newswires
03/29 17:16
FDA Converts to Full Approval Indication for KEYTRUDA® (pembrolizumab) for Certain Adult and Pediatric Patients With Advanced Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Solid Tumors
Yahoo
03/29 16:15
Stocks trade higher at the open, tech sees gains
Yahoo
03/29 09:42
Merck (MRK) Dips More Than Broader Markets: What You Should Know
Yahoo
03/28 17:45
12 Best Diversified Dividend Stocks to Buy Now
Yahoo
03/28 15:10
Gritstone bio draws Buy rating at B. Riley on mRNA potential
SA Breaking News
03/28 13:41
Merck Releases Keytruda Data In Frontline Endometrial Cancer Patients
Yahoo
03/28 12:50
Health Rounds: Waiting to remove lymph nodes may improve cancer immunotherapy
Yahoo
03/28 11:55
Merck's Keytruda successful in multiple types of endometrial cancer
SA Breaking News
03/27 18:16
KEYTRUDA® (pembrolizumab) Plus Chemotherapy Significantly Improved Progression-Free Survival Compared to Chemotherapy Alone as First-Line Therapy for Advanced or Recurrent Endometrial Carcinoma, Regardless of Mismatch Repair Status
Yahoo
03/27 17:15
Investors Heavily Search Merck & Co., Inc. (MRK): Here is What You Need to Know
Yahoo
03/27 09:00
What Makes Merck & Co. (MRK) A Strong Investment?
Yahoo
03/27 02:31
Who Are Pfizer's (PFE) Main Competitors?
Yahoo
03/25 13:38
Amplifying the Power of Women in Chemistry
Accesswire
03/22 15:45
The Zacks Analyst Blog Highlights Merck, Intel, MercadoLibre, The Travelers Companies and Halliburton
Yahoo
03/22 07:21
Merck (MRK) Stock Sinks As Market Gains: What You Should Know
Yahoo
03/21 17:45
Top Research Reports for Merck, Intel & MercadoLibre
Yahoo
03/21 10:52
7 Defensive Stocks to Buy During This Chaotic Spell
Yahoo
03/20 18:31
Merck, Viatris settle patent dispute over Januvia
SA Breaking News
03/20 17:02
Merck (MRK) Stock Up 31.6% in a Year: What Awaits in 2023?
Yahoo
03/20 06:26
Merck's (MRK) Co-formulation Therapy Fails Lung Cancer Study
Yahoo
03/17 12:56
Merck's Keytruda Combo Therapy Less Effective Than Chemo In Lung Cancer Patients, Data Shows
Yahoo
03/17 12:22
Merck Keytruda, anti-TIGIT therapy coformulation hits setback in mid-stage trial
SA Breaking News
03/17 11:37
UPDATE 1-Two new vaccines against bird flu effective in Dutch lab -govt
Yahoo
03/17 10:18
Merck’s combination therapy in lung cancer fails a Phase 2 clinical trial
Yahoo
03/17 08:08
FedEx, Nvidia and Bumble rise premarket; First Republic, Credit Suisse fall
Yahoo
03/17 04:09
Merck Says Open-Label Arm of Phase 2 Trial of MK-7684A to Treat Lung Cancer Didn't Reach Primary Endpoint
MT Newswires
03/16 17:09
Merck Provides Update from Open-Label Arm of Phase 2 KeyVibe-002 Trial Evaluating MK-7684A, a Coformulation of Vibostolimab and Pembrolizumab, in Previously Treated Patients with Metastatic Non-Small Cell Lung Cancer (NSCLC)
Yahoo
03/16 16:05
Medicare publishes initial guidance on drug price negotiations
SA Breaking News
03/16 14:15
Here is What to Know Beyond Why Merck & Co., Inc. (MRK) is a Trending Stock
Yahoo
03/14 09:00
Wells Fargo Downgrades Merck & Company to Equal Weight From Overweight, Adjusts Price Target to $115 From $120
MT Newswires
03/13 08:19
10 Best Psychedelic Stocks to Buy According to Hedge Funds
Yahoo
03/12 12:22
Merck's Keytuda+Chemo Combo Improves Overall Survival In Patients With Advanced Mesothelioma
Yahoo
03/10 10:48
Merck Says Phase 2/3 Trial of Combination Cancer Therapy Met Primary Endpoint of Overall Survival
MT Newswires
03/10 08:13
Berenberg Bank Adjusts Merck & Company Price Target to $130 From $125, Maintains Buy Rating
MT Newswires
03/10 07:31
KEYTRUDA® (pembrolizumab) Plus Chemotherapy Significantly Improved Overall Survival Versus Chemotherapy Alone as First-Line Treatment for Advanced Malignant Pleural Mesothelioma
Yahoo
03/10 06:45
Vaccinex KEYNOTE B-84 Enrollment Reaches Target for Interim Analysis
MT Newswires
03/09 10:49
OPKO Health's Cancer & Infectious Disease Focused Subsidiary Inks Vaccine Development Pact With Merck
Yahoo
03/08 12:01
OPKO Health Subsidiary Working With Merck to Develop Epstein-Barr Virus Vaccine Candidate
MT Newswires
03/08 10:11
Opko Health shares rise on Merck deal for experimental Epstein-Barr vaccine
Yahoo
03/08 08:05
Merck, Opko Health sign deal for experimental Epstein-Barr virus vaccine
Yahoo
03/08 08:01
Merck (MRK) Reports Detailed Data From PAH Study on Sotatercept
Yahoo
03/08 08:00
Merck to Present at the Barclays 2023 Global Healthcare Conference
Yahoo
03/08 06:45
Sleep-at-night stocks for those hedging or risk averse
SA Breaking News
03/08 06:41
Analyst Downgrades Gossamer Bio As Merck's Sotatercept Might Overshadow Seralutinib's Success
Yahoo
03/07 15:37
Black Scientists, Innovators and Employees are Key to Merck’s History of Invention and Progress
Yahoo
03/07 11:15
Credit Suisse Raises Merck & Co.'s Price Target to $126 From $125, Keeps Outperform Rating; Remains Top Pick in US Pharma
MT Newswires
03/07 08:27
Atlantic Equities Adjusts Price Target on Merck & Company to $127 From $122, Keeps Overweight Rating
MT Newswires
03/07 07:39
Merck posts full Phase 3 data for sotatercept in pulmonary arterial hypertension
SA Breaking News
03/07 05:30
Factory Orders Report Helps Drive Equities Mostly Higher
MT Newswires
03/06 16:25
Merck's Phase 2b Study of MK-0616 Showed Significant Reduction of Bad Cholesterol in Adults With Hypercholesterolemia
MT Newswires
03/06 16:01
Merck Highlights Promising Data From Two Candidates In Heart Diseases
Yahoo
03/06 15:47
Moderna hopes for FDA accelerated approval of cancer vaccine
SA Breaking News
03/06 15:09
Alternatives to Popular Cholesterol-Lowering Drug Cut Heart-Attack Risk
Yahoo
03/06 14:45
Merck to start phase 3 of oral PCSK9 inhibitor for cholesterol following mid-stage results
SA Breaking News
03/06 13:45
Seagen’s Cancer Therapy Is Making It a Takeover Target
Yahoo
03/06 12:29
UPDATE 1-Merck's drug boosts exercise capacity in pulmonary hypertension patients
Yahoo
03/06 12:11
Merck’s Investigational Activin Signaling Inhibitor Sotatercept Improved Six-Minute Walk Distance by 40.8 Meters at Week 24 Versus Placebo in Adults with Pulmonary Arterial Hypertension on Background Therapy
Yahoo
03/06 12:01
Merck's drug boosts exercise capacity in pulmonary hypertension patients
Yahoo
03/06 12:00
Merck’s MK-0616, an Investigational Oral PCSK9 Inhibitor, Significantly Reduced LDL-C in Patients with Hypercholesterolemia in Phase 2b Study
Yahoo
03/06 12:00
Merck's MMRV Vaccine Family Granted FDA-Approval for Intramuscular Injection
MT Newswires
03/06 07:53
Jefferies Initiates Merck at Buy With $125 Price Target
MT Newswires
03/06 07:35
US FDA Approves Intramuscular Administration for Merck’s MMRV Family of Vaccines: M-M-RII (Measles, Mumps, and Rubella Virus Vaccine Live), VARIVAX (Varicella Virus Vaccine Live), and ProQuad (Measles, Mumps, Rubella and Varicella Virus Vaccine Live)
Yahoo
03/06 06:45
Why Seagen is a top acquisition target?
SA Breaking News
03/05 12:00
Health exec: 'Publicly traded entities don’t necessarily understand clinical culture'
Yahoo
03/03 17:00
Is Trending Stock Merck & Co., Inc. (MRK) a Buy Now?
Yahoo
03/03 09:00
Merck, AstraZeneca Say US FDA's Panel to Review Cancer Drug Lynparza on April 28
MT Newswires
03/02 12:47